Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

Toward fulfilling the promise of molecular medicine in fragile X syndrome.

Krueger DD, Bear MF.

Annu Rev Med. 2011;62:411-29. doi: 10.1146/annurev-med-061109-134644. Review.

PMID:
21090964
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The state of synapses in fragile X syndrome.

Pfeiffer BE, Huber KM.

Neuroscientist. 2009 Oct;15(5):549-67. doi: 10.1177/1073858409333075. Epub 2009 Mar 26. Review.

PMID:
19325170
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.

Bassell GJ, Warren ST.

Neuron. 2008 Oct 23;60(2):201-14. doi: 10.1016/j.neuron.2008.10.004. Review.

PMID:
18957214
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse.

Ronesi JA, Huber KM.

Sci Signal. 2008 Feb 5;1(5):pe6. doi: 10.1126/stke.15pe6. Review.

PMID:
18272470
[PubMed - indexed for MEDLINE]
5.

Mechanism-based approaches to treating fragile X.

Dölen G, Carpenter RL, Ocain TD, Bear MF.

Pharmacol Ther. 2010 Jul;127(1):78-93. doi: 10.1016/j.pharmthera.2010.02.008. Epub 2010 Mar 18. Review.

PMID:
20303363
[PubMed - indexed for MEDLINE]
6.

Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.

De Rubeis S, Fernández E, Buzzi A, Di Marino D, Bagni C.

Adv Exp Med Biol. 2012;970:517-51. doi: 10.1007/978-3-7091-0932-8_23. Review.

PMID:
22351071
[PubMed - indexed for MEDLINE]
7.

The pathophysiology of fragile X (and what it teaches us about synapses).

Bhakar AL, Dölen G, Bear MF.

Annu Rev Neurosci. 2012;35:417-43. doi: 10.1146/annurev-neuro-060909-153138. Epub 2012 Apr 5. Review.

PMID:
22483044
[PubMed - indexed for MEDLINE]
8.

Molecular mechanisms of fragile X syndrome: a twenty-year perspective.

Santoro MR, Bray SM, Warren ST.

Annu Rev Pathol. 2012;7:219-45. doi: 10.1146/annurev-pathol-011811-132457. Epub 2011 Oct 10. Review.

PMID:
22017584
[PubMed - indexed for MEDLINE]
9.

The role of fragile X mental retardation protein in major mental disorders.

Fatemi SH, Folsom TD.

Neuropharmacology. 2011 Jun;60(7-8):1221-6. doi: 10.1016/j.neuropharm.2010.11.011. Epub 2010 Nov 22. Review.

PMID:
21108954
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The translation of translational control by FMRP: therapeutic targets for FXS.

Darnell JC, Klann E.

Nat Neurosci. 2013 Nov;16(11):1530-6. doi: 10.1038/nn.3379. Epub 2013 Apr 14. Review.

PMID:
23584741
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Fragile X: leading the way for targeted treatments in autism.

Wang LW, Berry-Kravis E, Hagerman RJ.

Neurotherapeutics. 2010 Jul;7(3):264-74. doi: 10.1016/j.nurt.2010.05.005. Review.

PMID:
20643379
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The mGluR theory of fragile X mental retardation.

Bear MF, Huber KM, Warren ST.

Trends Neurosci. 2004 Jul;27(7):370-7. Review.

PMID:
15219735
[PubMed - indexed for MEDLINE]
13.

Differential translation and fragile X syndrome.

Vanderklish PW, Edelman GM.

Genes Brain Behav. 2005 Aug;4(6):360-84. Review.

PMID:
16098135
[PubMed - indexed for MEDLINE]
14.

Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond.

Gross C, Berry-Kravis EM, Bassell GJ.

Neuropsychopharmacology. 2012 Jan;37(1):178-95. doi: 10.1038/npp.2011.137. Epub 2011 Jul 27. Review.

PMID:
21796106
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Fragile X syndrome: from molecular genetics to therapy.

D'Hulst C, Kooy RF.

J Med Genet. 2009 Sep;46(9):577-84. doi: 10.1136/jmg.2008.064667. Review.

PMID:
19724010
[PubMed - indexed for MEDLINE]
16.

Fragile X syndrome and targeted treatment trials.

Hagerman R, Lauterborn J, Au J, Berry-Kravis E.

Results Probl Cell Differ. 2012;54:297-335. doi: 10.1007/978-3-642-21649-7_17. Review.

PMID:
22009360
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Emerging pharmacotherapies for neurodevelopmental disorders.

Wetmore DZ, Garner CC.

J Dev Behav Pediatr. 2010 Sep;31(7):564-81. doi: 10.1097/DBP.0b013e3181ee3833. Review.

PMID:
20814256
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Fragile X syndrome and model organisms: identifying potential routes of therapeutic intervention.

Bhogal B, Jongens TA.

Dis Model Mech. 2010 Nov-Dec;3(11-12):693-700. doi: 10.1242/dmm.002006. Epub 2010 Aug 3. Review.

PMID:
20682752
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Neuroanatomical, molecular genetic, and behavioral correlates of fragile X syndrome.

Koukoui SD, Chaudhuri A.

Brain Res Rev. 2007 Jan;53(1):27-38. Epub 2006 Jul 17. Review.

PMID:
16844227
[PubMed - indexed for MEDLINE]
20.

Fragile X mental retardation protein in plasticity and disease.

Todd PK, Malter JS.

J Neurosci Res. 2002 Dec 1;70(5):623-30. Review.

PMID:
12424729
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk